NORML

MARCH 1, 2019

In August 2016, the US Drug Enforcement Administration announced in the US Federal Register that the agency was “adopting a new policy that is designed to increase the number of entities registered under the Controlled Substances Act to grow (manufacture) marijuana to supply legitimate researchers in the United States.”

DEA 187

DEA Research and Development Clinical Trials Marijuana 187

NORML

OCTOBER 21, 2019

Justices for the US Court of Appeals for the District of Columbia denied the petition following a filing by DEA in the Federal Register stating that the agency “intends to promulgate regulations” to review several dozen federal cultivation applications.

DEA 105

DEA Cultivation Clinical Trials Policy 105

MJ Business Attorneys

JUNE 29, 2018

Moreover, the ball is in the Drug Enforcement Agency’s (DEA) court. The FDA can make recommendations to the DEA about substances subjected to scheduling under the CSA, but the DEA is the entity with the power to reschedule CBD. In the recent case Hemp Industries Associations v.

DEA 113

DEA CBD Pharmaceutical Research and Development 113

WeedAdvisor

AUGUST 28, 2019

Despite a 90-day deadline for review, the DEA ignored this cut-off and simply sat on the applications for three years. This likely would have been longer, but the DEA had not anticipated a legal threat to force some action. Given the DEA’s stonewalling, forcing their hand is a notable achievement. Dozens of Applications”. .

DEA 61

DEA Marijuana History THC 61

Veriheal

JANUARY 16, 2024

This occasion marks the first time that a federal agency has recommended rescheduling cannabis, and this could be the push the Drug Enforcement Administration (DEA) needs to finally make it happen. It may also result in federal legalization and easier access in states that have yet to legalize medicinal or recreational marijuana.

DEA 122

DEA Medicine Cannabis Legalization 122

Cannabis Law Report

DECEMBER 7, 2021

On November 16, 2021, the Drug Enforcement Agency (DEA) issued an advance notice of proposed rulemaking , exploring whether or not to create new federal regulations governing the practice of telepharmacy. The DEA’s notice provides the industry with an opportunity to provide insight and feedback that may help shape the new regulations.

DEA 52

DEA Patients Therapy Access 52

Veriheal

FEBRUARY 23, 2024

As the Drug Enforcement Administration (DEA) and federal government draw closer to moving cannabis from a Schedule I to a Schedule III substance , more groups have begun to put their weight behind the movement. Countless veterans suffer from these ailments, and, as such, are pushing for access to as many treatments and therapies as possible.

DEA 104

DEA Chronic Pain Treatment Therapy 104

Cannabis Law Report

JULY 7, 2021

Pennington, who focuses on federal appeals and regulatory issues, is co-counsel on several high-profile cases against the DEA regarding cannabis research, hemp, and psychedelics. Circuit), a pending petition for review of DEA’s August 2020 Interim Final Rule purportedly implementing the 2018 Farm Bill’s amendments to the CSA.

DEA 85

DEA Hemp Cultivation Advocacy 85

The Blunt Truth

MAY 15, 2020

The latest proposal submitted by House Democrats, entitled the HEROES Act, includes a provision that would allow “…access to financial services to cannabis-related legitimate businesses and service providers…” The language is from the SAFE Banking Act passed by the House last year. So let’s get started.

Banking 106

Banking Research and Development Programs Advocacy 106

Veriheal

SEPTEMBER 13, 2022

It also may be more convenient to grow cannabis at home if a consumer lives in a rural area or in a state that only has a limited number of accessible dispensaries. Consumers are getting fed up with only having access to the same limited set of genetics in the dispensary. Homegrown cannabis gives all the power to the consumer.

Cultivation 111

Cultivation Data DEA Dispensary 111

Veriheal

JUNE 30, 2023

A study investigated psilocybin’s effect on alcohol addiction, the FDA outlined best practices for future psychedelic research, and the NCAA is inching toward cannabis policy change. Lastly, the guide lays out the complex DEA registration process researchers much navigate to gain access to plants like psilocybin.

Clinical Trials 98

Clinical Trials Research and Development Therapy Policy 98

Cannabis Law Report

JUNE 16, 2022

NORML’s Political Director Morgan Fox added: “The fact that these interdiction efforts are growing — at great cost to the taxpayer — despite increasing momentum for legalization is a testament to the failure of federal prohibition and unnecessarily burdensome state regulatory policies.

DEA 52

DEA Marijuana Programs Data 52

Cannabis Law Report

JULY 1, 2021

The Project on Psychedelics Law and Regulation at the Petrie-Flom Center for Health Law Policy, Biotechnology, and Bioethics at Harvard Law School will advance evidence-based psychedelics law and policy. Mason Marks: The project’s goal is to promote safety, innovation, equity, and accessibility in emerging psychedelics industries.

Law 81

Law Research and Development Therapy DEA 81

Canna Law Blog

MARCH 4, 2020

Whomever on site is administering, manufacturing, storing, or distributing the drug, from the doctor to the nurse practitioner to the on-site pharmacist, must register with the DEA in accordance with Part 1301 of Title 21 of the Code of Federal Regulations on and after August 12, 1999.

Therapy 104

Therapy Legalization Chronic Pain DEA 104

Veriheal

NOVEMBER 6, 2023

Despite this massive shift in cannabis policy, however, a few states are still dragging their feet on cannabis legalization. The Act aimed to provide patients access to smokable flower for 15 medical conditions. This progressive legislation, once implemented, means a brand new slew of patients will have access to cannabis medicine.

Legalization 119

Legalization Recreational THC CBD 119

Cannabis Law Report

OCTOBER 4, 2021

Accordingly, it cannot be prescribed by a physician and it is not legally accessible to those who might benefit from it as a therapeutic treatment. Access Pursuant to the Oregon Psilocybin Services Act. The shelter provided by this approach depends on the policy of the U.S. Source: [link].

Therapy 52

Therapy Patients Law Clinical Trials 52

SMPL

AUGUST 14, 2019

The American Bar Association (ABA) adopted a resolution on Monday that calls on Congress to allow states to set their own marijuana policies and recommends rescheduling or descheduling cannabis under federal law. One area that could be quickly improved is in the sourcing of research-grade marijuana.

Policy 40

Policy Research and Development Marijuana DEA 40

Veriheal

AUGUST 24, 2022

This campaign was backed by New Approach PAC, a nationwide political organization that is focused on supporting progressive reform surrounding cannabis and criminal justice policies. So much, in fact, that it actually gained the attention of the DEA , which recently called for an increase in psychedelic production for research purposes.

Legalization 111

Legalization Decriminalization Medicine Research and Development 111

Cannabis Law Report

SEPTEMBER 1, 2021

3] Further, notwithstanding the determination of the Drug Enforcement Administration (DEA), which is required to defer to the Department of Health and Human Services’ assessment that cannabis has no acceptable medical utility, 37 states and four territories have enacted laws allowing for the medical use of cannabis products. [4] Conclusion.

Policy 100

Policy Cannabis Law Treatment 100

Dykema (Cannabis Law Blog)

OCTOBER 6, 2023

From a policy standpoint, there are pros and cons to this approach. On the one hand, this kind of decrim bill arguably democratized access to psychedelics. On the other hand, with no laws or regulations around the production of the plants and fungi, there is no framework for safety or quality control (i.e., What camp are you in?

Consumption 58

Consumption DEA Decriminalization Access 58

Cannabis Law Report

JANUARY 14, 2020

CLICK IMAGE TO ACCESS COMMITTEE INFO PAGE. Senior Policy Advisor, Diversion Control Division. Amidst growing evidence that marijuana can be used to effectively treat post-traumatic stress disorder , this bill from California Democrat Barbara Lee focuses on greatly expanding access to medical marijuana for veterans. Legislation.

Clinical Trials 69

Clinical Trials Programs Access DEA 69

Veriheal

DECEMBER 27, 2022

Researchers have taken a big step in understanding the connection between using psychedelics and feeling connected to nature in a study published in the journal Drug Science, Policy, and Law on Oct. Study findings indicated that those who had previously taken LSD and psilocybin reported a greater sense of “nature relatedness.”

Research and Development 102

Research and Development Therapy Consumption DEA 102

Burns Levinson (Cannabusiness advisory)

OCTOBER 3, 2018

This marks the first time in history that the DEA has removed any type of cannabis from Schedule I, and clears the way for the sale of the first non-synthetic, cannabis-derived medicine to win federal approval. According to the DEA order, because the drug was recently approved by the FDA, it is now considered to have an accepted medical use.

CBD 40

CBD DEA Epilepsy Pharmaceutical 40

Cannabis Law Report

JUNE 15, 2021

. – Today, ahead of the 50th anniversary—on June 17—of when President Richard Nixon declared the “war on drugs,” Representatives Bonnie Watson Coleman (D-NJ) and Cori Bush (D-MO) unveiled the Drug Policy Reform Act (DPRA), alongside the Drug Policy Alliance, which has been a strategic partner on the development of the legislation.

Decriminalization 60

Decriminalization Policy Research and Development Data 60

Veriheal

AUGUST 19, 2022

But times are changing, and leaders are now calling for revamped policies on psilocybin, hemp, and cannabis research for varying reasons. ” Cannabis Research Should Be Based on Real, Accessible Products. The DEA stated that they were starting the process of approving additional cannabis cultivators back in 2016.

Hemp 52

Hemp DEA Access Cultivation 52

Cannabis Law Report

MARCH 6, 2019

The DEA couldn’t figure out at first why a bunch of rednecks in Cottondale, Florida, had 24-carat gold Rolex watches and were driving Mercedes S500’s, Cobb told Fox News in a recent interview. Brady Cobb estimates that before his dad was finally busted, in 1983, he had pulled in more than $300 million of Escobar’s drug money.

Banking 78

Banking Policy Legislation Compliance 78

PrestoDoctor

JULY 16, 2019

Today, groups with a decade or less of experience advance policy and conversations alongside the veteran alliances of the movement. NORML acts as a resource for media on cannabis, as well as informs lawmakers, lobbies and other top officials regarding policy. The Drug Policy Alliance (DPA). The Drug Policy Alliance (DPA).

Policy 40

Policy DEA Access Media 40

PrestoDoctor

JULY 16, 2019

Today, groups with a decade or less of experience advance policy and conversations alongside the veteran alliances of the movement. NORML acts as a resource for media on cannabis, as well as informs lawmakers, lobbies and other top officials regarding policy. The Drug Policy Alliance (DPA). The Drug Policy Alliance (DPA).

Policy 40

Policy DEA Access Media 40

Sensi Seeds

NOVEMBER 28, 2018

Irrespective of where the directive came from, policy on CBD has changed. Some companies who were reportedly affected by the policy update include Gea Seeds, Grow Barato, and HortiTec who received a letter from AECOSAN, and were subsequently raided. CBD Regulation is Needed.

CBD 71

CBD Seed-To-Sale Food Research and Development 71

Cannabis Law Report

MAY 28, 2022

Despite progress over the past decade, the cannabis industry still struggles to access a fundamental piece of the U.S. The cannabis industry might look like just another business for local police, where legal, but the DEA and other federal agencies have a different outlook. economy: the financial system. The State of Banking.

Banking 52

Banking State Laws Law DEA 52

Cannabis Law Report

JULY 14, 2021

Legislation opens doors for cannabis policy reform in the current Congress. Cory Booker (D-NJ) and Ron Wyden (D-OR), released draft legislation today that would remove cannabis from the schedule of controlled substances while allowing states to determine their own cannabis policies. WASHINGTON, D.C. But this alone is not enough.

Legislation 71

Legislation Banking History Access 71

Cannabis Law Report

AUGUST 12, 2022

Drug policy topics have become a consistent feature of the Austin-based event in recent years as more states have legalized cannabis and moved to reform laws around psychedelics like psilocybin locally and at the state level. The panel would center on the evolution of cannabis policy in the U.S.,

Research and Development 52

Research and Development Topical Events Policy 52

Cannabis Law Report

JUNE 9, 2021

But the Drug Enforcement Administration (DEA) is equipped to mete out maximum penalties of up to five years in prison and a $250,000 fine for anyone transporting less than 50kg of marijuana—even for a first-time offense. If you only take one message away from this post, please for the sake of my sanity, let it be that one.

Marijuana 66

Marijuana Edibles DEA THC 66

Cannabis Law Report

APRIL 8, 2022

Later that year, Doblin sued the DEA for the first time. MAPS hired Sylvia Thyssen as our first employee , celebrated the 50th anniversary of LSD , outlined perspectives on drug policy , and worked toward facilitating a pilot study for medical marijuana. Lyle Craker, Ph.D., MAPS Founder Rick Doblin, Ph.D.,

Clinical Trials 52

Clinical Trials Therapy Research and Development DEA 52

Cannabis Law Report

APRIL 24, 2019

Such actions by the federal will create some very difficult paths because of policy distinctions arising from individual rights, public protections, commercial activities, health and safety, use of resources, etc.]. We are not going to attempt to tackle the myriad policy issues of this alternative, but we do have some observations.

Legalization 58

Legalization Collective DEA Banking 58

Cannabis Law Report

SEPTEMBER 29, 2021

The membership subsequently met with the USDA’s new Hemp Work Group, and White House officials that serve the President on agriculture and drug control policy. Senators) who joined the group in a spirited, interactive discussion on hemp public policy. The national media took notice of some of the highlights: Rep. By David McGee.

Hemp 52

Hemp Banking Legislation Policy 52

Cannabis Law Report

SEPTEMBER 23, 2019

During the 20 th century, law enforcement and public policy activities have undermined opportunities for scientific exploration. Relevant AAFP Policy. Family physicians have a vested interest in policies that advance and protect the health of their patients and the public. Marijuana Possession for Personal Use. Call to Action.

Cannabinoids 40

Cannabinoids Marijuana Research and Development Access 40